コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 formation, key to optimizing these devices, is lacking.
2 coronavirus disease 2019 (COVID-19) pandemic is lacking.
3 s driving the ectendomycorrhizal interaction is lacking.
4 n many tissues but information on the cornea is lacking.
5 of consent, and potential harms and benefits is lacking.
6 of the population) and purifying selection, is lacking.
7 of care, but a direct randomised comparison is lacking.
8 oup's order, but empirical evidence for this is lacking.
9 ect experimental evidence for this mechanism is lacking.
10 ecipitation, but a mechanistic understanding is lacking.
11 al resolution and blood flow-resolving speed is lacking.
12 ments, while support from natural ecosystems is lacking.
13 ow cells integrate multi-dimensional signals is lacking.
14 in the context of their functional proteomes is lacking.
15 ction (MET) complex, but conclusive evidence is lacking.
16 tion of the de novo proteome in this process is lacking.
17 nteraction between pathways in PPR pathology is lacking.
18 of suitable reference genes in these subsets is lacking.
19 hetics at their physiological receptor sites is lacking.
20 s are being reported, but comprehensive data is lacking.
21 new and/or duplicated genes to NCC evolution is lacking.
22 d definition of remission of type 2 diabetes is lacking.
23 ad, direct evidence for the individual steps is lacking.
24 f probiotics in routine preterm newborn care is lacking.
25 ity, and mechanisms of carbapenem resistance is lacking.
26 naling between microbes and sensory neurons, is lacking.
27 of how these pathways collaborate in animals is lacking.
28 eriences; however, direct empirical evidence is lacking.
29 unctional relevance in human satellite cells is lacking.
30 zed to infer outcomes when direct experience is lacking.
31 Molecular insight into this checkpoint is lacking.
32 system, required to substantiate this idea, is lacking.
33 ietic changes caused by heterochromatin loss is lacking.
34 ric MRI; however, histopathologic validation is lacking.
35 nection between EMC1 and these birth defects is lacking.
36 detailed analysis of melanopsin's activation is lacking.
37 However, quality data from large studies is lacking.
38 ular-level understanding of such enhancement is lacking.
39 e of uranium to natural waters, yet evidence is lacking.
40 ation of the T2 literature for normal values is lacking.
41 adaptations to weight loss and weight regain is lacking.
42 homologs, called ONE-HELIX PROTEINS (OHPs), is lacking.
43 sive approach to identify biomarkers of irAE is lacking.
44 tudies and direct evidence for this function is lacking.
45 al evidence for this functional relationship is lacking.
46 ess, specifically starvation-induced stress, is lacking.
47 ally regulated genes and associated networks is lacking.
48 hydrodynamic analysis supporting this claim is lacking.
49 the self-coupling of CO to valuable products is lacking.
50 on which to choose for a particular patient is lacking.
51 but a systematic quantitative investigation is lacking.
52 mine, although biochemical evidence for this is lacking.
53 racteristics and consequences for crop yield is lacking.
54 ction, and especially substrate specificity, is lacking.
55 prehensive mapping of human cardiac fuel use is lacking.
56 cells (PSCs); however, experimental evidence is lacking.
57 type developed on a large and diverse sample is lacking.
58 , but a structural basis for the differences is lacking.
59 analysis and candidate gene identification, is lacking.
60 ysiological evidence across the human cortex is lacking.
61 cine types elicit durable antibody responses is lacking.
62 rmation regarding specific brainstem regions is lacking.
63 r understanding of why they are so effective is lacking.
64 s, especially where manufacturer competition is lacking.
65 heterogeneity in response to cardiac damage is lacking.
66 ary care settings in underserved populations is lacking.
67 te and risk factors for complications of RFA is lacking.
68 effective targeted therapy for pancreatitis is lacking.
69 y sets the permeability of epithelial tissue is lacking.
70 comprehensive knowledge of their composition is lacking.
71 splantation (HCT) in the pediatric age group is lacking.
72 nectivity of individual serotonergic neurons is lacking.
73 of these compounds with thyroid cancer (TC) is lacking.
74 diovascular disease at a sub-daily timescale is lacking.
75 c applications, but a complete understanding is lacking.
76 ulating IMVR and insulin sensitivity in vivo is lacking.
77 rate that a biological response has occurred is lacking.
78 GPCRs, but its characterization for the GCGR is lacking.
79 ients remember from alcohol-related episodes is lacking.
80 e information that connects these structures is lacking.
81 ion leads to the development of colon cancer is lacking.
82 obal synthesis of their effects on hydrology is lacking.
83 er (PCa), but validation with histopathology is lacking.
84 ature, yet a comprehensive comparative study is lacking.
85 ively renormalizes datasets without spike-in is lacking.
86 red because corroborating evidence in humans is lacking.
87 anscriptomic profiling in early pediatric AD is lacking.
88 an in-depth profiling of those cells in MDD is lacking.
89 the natural ecology of NTM, such as hypoxia, is lacking.
90 otein activity function together as a system is lacking.
91 dence of its in vivo efficacy and durability is lacking.
92 ase 2019 (Covid-19), but definitive evidence is lacking.
93 the relative efficacy of various treatments is lacking.
94 pneumonia in low-resource settings in Africa is lacking.
95 in the highly turbulent atmosphere of Saturn is lacking.
96 ic visualisation in pathogen-infected tissue is lacking.
97 ntegrated molecular knowledge of EN subtypes is lacking.
98 ological artifacts, although direct evidence is lacking.
99 acterization of the convertase formed by C4b is lacking.
100 rstanding of what regulates FGF23 production is lacking.
101 all guidance on efficient pooling strategies is lacking.
102 ps are reproducibly evaluated and documented is lacking.
103 wide, the quality control of these libraries is lacking.
104 echanistic understanding of this association is lacking.
105 tcomes of large NAFLD-associated HCC cohorts are lacking.
106 o patients who received preoperative therapy are lacking.
107 he COVID-19 pandemic but reports of outcomes are lacking.
108 metabolism, and excretion (ADME) properties are lacking.
109 Such panels for breast cancer are lacking.
110 nd the tuberculin skin test (TST) among PLWH are lacking.
111 s of synaptic reorganization and plasticity) are lacking.
112 to target MYC activity in RAS-driven cancers are lacking.
113 y to pathogenic amyloid-beta (Abeta) in LOAD are lacking.
114 ating the clinical impact of this technology are lacking.
115 exogenous transcription regulatory proteins are lacking.
116 of the available risk assessment techniques are lacking.
117 ve to infectious risk and allograft function are lacking.
118 ted with HLH but molecular epidemiology data are lacking.
119 e measures, as specific treatment strategies are lacking.
120 ntial of isoform-selective enzyme modulation are lacking.
121 es for the integrative analysis of such data are lacking.
122 s, but studies on the role of SULT1E1 in AKI are lacking.
123 ed phenotypes to underlying error mechanisms are lacking.
124 pressures and temperatures of core formation are lacking.
125 n underlie biological embedding, causal data are lacking.
126 hragmatic function recovery after extubation are lacking.
127 ns limited and effective therapeutic options are lacking.
128 but large-scale, real-world data on its use are lacking.
129 ntions among IDPs, locally sourced solutions are lacking.
130 , but approaches to increase or preserve ATP are lacking.
131 Data on H1N1 influenza infection are lacking.
132 , and specific anti-enterovirus therapeutics are lacking.
133 al assessments of this telencephalic nucleus are lacking.
134 o measure E/I ratios in human brain networks are lacking.
135 ghts into its immune recognition and control are lacking.
136 perspective, but studies for the spinal cord are lacking.
137 ance assessments based on held-out test data are lacking.
138 ve therapies for improving clinical outcomes are lacking.
139 eir regulation and contribution to migration are lacking.
140 he functional importance of each phosphosite are lacking.
141 curate models to predict inpatient mortality are lacking.
142 e strategies to induce new HFs in adult skin are lacking.
143 T cells with a cytotoxic expression profile are lacking.
144 tify BE patients from the general population are lacking.
145 dovascular versus surgical revascularization are lacking.
146 lectively halogenate pyridine C-H precursors are lacking.
147 blind ultraviolet-C wavelengths (200-280 nm) are lacking.
148 However, data regarding long-term mortality are lacking.
149 studies comparing outcomes for MIPD and OPD are lacking.
150 ynamics of leukocytes non-invasively in vivo are lacking.
151 t groups; similar data in pediatric patients are lacking.
152 ients subjected to surgery for rectal cancer are lacking.
153 ementation to prevent tuberculosis infection are lacking.
154 cure and effective pharmacological therapies are lacking.
155 Borneo's coastal and coral reef environments are lacking.
156 c early regulatory functions of the dynamins are lacking.
157 udies focusing on severe allergic phenotypes are lacking.
158 th established coronary heart disease (CHD), are lacking.
159 se, but longitudinal natural history studies are lacking.
160 the cellular loci and mechanisms responsible are lacking.
161 ectrum prescriptions in all febrile children are lacking.
162 s of global chromatin compaction upon damage are lacking.
163 ically driven tumors for which model systems are lacking.
164 pe and content of these inclusions in detail are lacking.
165 but validated estimates of personalized risk are lacking.
166 ract but studies evaluating combined effects are lacking.
167 arasite age post-invasion in patient samples are lacking.
168 ma biomarkers of subclinical atherosclerosis are lacking.
169 ar-round, but nationally representative data are lacking.
170 Long-term oncologic results, however, are lacking.
171 is methods that integrate both types of data are lacking.
172 duction at county scale across mutiple years are lacking.
173 subsequent risk of invasive cervical cancer are lacking.
174 illness and other objective health measures are lacking.
175 to define precise metabolic risk phenotypes are lacking.
176 sive software tools to support such analyses are lacking.
177 Pre-pubertal models are lacking.
178 mud, principles of motion on such materials are lacking.
179 term randomized data that test this paradigm are lacking.
180 acterized, in part because longitudinal data are lacking.
181 , and therapeutic targets for its modulation are lacking.
182 virus (HIV+ patients), but longitudinal data are lacking.
183 w on individuals and populations in the wild are lacking.
184 vironments, but the tools to test its limits are lacking.
185 However, studies including treatment details are lacking.
186 ules for the coexistence of condensed phases are lacking.
187 biomarkers of response to systemic therapies are lacking.
188 echanism between ischemia and Abeta toxicity are lacking.
189 activity across this brainstem-wide circuit are lacking.
190 phylogenetic resolution or clear apomorphies are lacking.
191 ting and MRD-directed therapy after allo-HCT are lacking.
192 ase, but large-scale high-resolution studies are lacking.
193 on the long-term durability of these valves are lacking.
194 SA for primary prophylaxis in these patients are lacking.
195 tegies to enhance Trm responses at this site are lacking.
196 activity, yet data to inform such decisions are lacking.
197 otemporal dementia (FTD), however biomarkers are lacking.
198 f light sedation, has an effect on mortality are lacking.
199 men (MSM), as routine universal testing data are lacking.
200 stereoisomeric dimers from a single monomer are lacking.
201 linical data concerning effects on cognition are lacking.
202 igh folate status to adverse health outcomes are lacking.
203 ts transplanted for primary immunodeficiency are lacking.
204 lines for Americans (PA Guidelines) on NAFLD are lacking.
205 ies on the co-aggregation of these disorders are lacking.
206 elapsing-remitting multiple sclerosis (RRMS) are lacking.
207 nts with established coronary artery disease are lacking.
208 rts of knots in a synthetic nanoscale strand are lacking.
209 tive and worldwide data regarding this topic are lacking.
210 recapitulating PAF without motor dysfunction are lacking.
211 structural information for the mammalian NHE was lacking.
212 Until now, the ability to study these events was lacking.
213 ation approvals, and consensus when evidence was lacking.
214 duction in the past, but conclusive evidence was lacking.
215 ging that an accurate preventable death rate was lacking.
216 paran sulfate (HS), but the in vivo evidence was lacking.
217 h insurance receive maintenance dialysis has been lacking.
218 ole-organism analysis of ageing dynamics has been lacking.
219 ear, as technology to track them in situ has been lacking.
220 types and altered sphingolipid synthesis has been lacking.
221 nt with regard to long-term variability have been lacking.
222 sequent modulation of plastid proteomes, has been lacking.
223 act emerge at particular points in time has been lacking.
224 , although data to test this hypothesis have been lacking.
225 of hot carriers in nanostructures has so far been lacking.
226 e targeting for therapeutic application have been lacking.
227 ersity, particularly during development, has been lacking.
228 us analytic pipeline for nuclear RNA-seq has been lacking.
229 le trends specific to an infection area have been lacking.
230 ively assess these interactions within cells were lacking.
231 pport action potentials, but definitive data were lacking.
236 selectively inhibit a single BET bromodomain are lacking, although pan inhibitors of the first (D1),
238 he impact of food advertising in adolescents is lacking and no prior research has investigated neural
239 ution studies in support of such a mechanism were lacking and how 'opening' is brought about remained
240 rmaceuticals, transparency and communication are lacking, and some utilization management may disprop
241 e, broadly generalizable patient populations are lacking, and the effect of body mass index (BMI) on
243 in patients with spontaneous cerebellar ICH are lacking, and the risk of bias in published series is
244 g Her2 which can be used in clinical routine are lacking, and therefore, the development of novel inh
246 This is significant as such information has been lacking, and it will open an exciting research dire
248 raging results; however, long-term follow-up is lacking, and the safety and efficacy concerns of geno
251 rhosis + hepatocellular carcinoma), but data are lacking at the local level (eg, county) to identify
253 rdized diagnostic algorithms and definitions are lacking, clinicians are reticent to perform aerosol-
254 immunologic responses to neuraminidase (NA) is lacking compared to what is available on hemagglutini
255 Specifically, sleep studies in mosquitoes are lacking despite considerable focus on how circadian
256 lity on within-species behavioural diversity are lacking despite the critical assumption that populat
258 of the putative PC-1/PC-2 polycystin complex is lacking due to technical hurdles in reliably measurin
259 the ecological effects of non-native species are lacking, even though such knowledge is fundamental t
261 ecially with regards to alternative splicing-are lacking for most primary cell types, including plate
262 ng radiation on the STT-MRAM writing process are lacking for MTJs with perpendicular magnetic anisotr
266 atest toxic potency, analytical methods have been lacking for quantifying complete classes of most to
270 Although a universally accepted definition is lacking, for the purpose of this review we define RLP
277 Notably, a number of pollen-specific genes were lacking in Arabidopsis, and the number of genes inv
280 NA-seq quantification tools tailored for TEs are lacking, limiting our ability to dissect TE expressi
282 tumors, and established systemic treatments are lacking.METHODSWe used next-generation sequencing an
283 , but clarity on the optimal dosing approach is lacking.Objectives: To characterize rifapentine popul
286 for a primary ventral hernia, but consensus is lacking on the management in women who might subseque
287 ly with intermittent dosing, and information is lacking on the relationship between the host transcri
290 ic clinical trials to guide treatment of VTE is lacking so treatment is often extrapolated from adult
293 rect head-to-head comparisons of biologicals are lacking; therefore, algorithms for initial choice an
295 well as when microtubule nucleating activity is lacking, uncovering further diversity in the mechanis
296 s cognitive flexibility during early infancy are lacking, we aimed to assess the spatiotemporal devel
297 e graft viability and performance assessment are lacking, we applied this novel technique to human ki
299 ng intact antibodies under native conditions are lacking, we developed a straightforward NMR approach
300 bout DNA transfer within complex microbiomes is lacking, with most studies of horizontal gene transfe